Guardant Health (GH) Stock Sinks As Market Gains: What You Should Know
Guardant Health (GH) closed the most recent trading day at $66.12, moving -1.9% from the previous trading session. This change lagged the S&P 500's 0.11% gain on the day. Meanwhile, the Dow gained 0.04%, and the Nasdaq, a tech-heavy index, added 0.19%.
Coming into today, shares of the provider of oncology testing services had lost 8.55% in the past month. In that same time, the Medical sector lost 4.15%, while the S&P 500 gained 4.42%.
Wall Street will be looking for positivity from GH as it approaches its next earnings report date.
Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of -$1.50 per share and revenue of $133.33 million. These totals would mark changes of +46.43% and +47.1%, respectively, from last year.
Any recent changes to analyst estimates for GH should also be noted by investors. Recent revisions tend to reflect the latest near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.
Our research shows that these estimate changes are directly correlated with near-term stock prices. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 3.98% lower. GH is currently sporting a Zacks Rank of #3 (Hold).
The Medical - Biomedical and Genetics industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 72, which puts it in the top 29% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Guardant Health, Inc. (GH) : Free Stock Analysis Report
To read this article on Zacks.com click here.
